
Vimistal 1mg Oral Suspension
Marketer
Eden Healthcare Pvt Ltd
Salt Composition
Domperidone (1mg/ml)
Overview Vimistal 1mg Oral Suspension
Pedialax 1mg oral suspension offers relief from indigestion, gastroesophageal reflux, nausea, and vomiting in children. It accelerates digestive transit, easing symptoms like bloating, satiety, and stomach upset. Administer Pedialax 1mg half an hour before meals for optimal efficacy; post-meal administration remains effective, though absorption might be slightly reduced. Infants may receive a doctor-prescribed four times daily dosage, spaced at least four hours apart, ideally just before a feeding. Dosage varies based on individual needs, weight, and age. Never extend treatment beyond the prescribed period without consulting a physician. If vomiting occurs within 30 minutes of ingestion, repeat the dose after the child has settled; avoid doubling if the next dose is imminent. Minor, transient side effects such as dry mouth, headache, drowsiness, abdominal cramping, and diarrhea may occur, typically resolving with continued use. Persistent or troubling side effects warrant immediate medical attention. Inform your child's physician of any prior allergies, heart conditions, blood disorders, congenital anomalies, respiratory issues, lung abnormalities, gastrointestinal problems, skin conditions, liver dysfunction, or kidney impairment. A complete medical history aids in accurate dosage adjustments and comprehensive treatment planning.
Uses of Vimistal 1mg Oral Suspension
Managing gastroesophageal reflux disease (GERD), indigestion, nausea, and vomiting.
Major Benefits of Vimistal 1mg Oral Suspension:
Administer this medication orally, following your physician's prescribed dosage and schedule. Always refer to the product label for instructions prior to consumption. Use a measuring device for accurate dosing. Ensure thorough shaking before each use. Consume Vimistal 1mg Oral Suspension on an empty stomach.
Common Side effects of Vimistal 1mg Oral Suspension:
- Dryness in mouth
- Headache
- Drowsiness
- Stomach cramp
- Diarrhea
How to use Vimistal 1mg Oral Suspension:
Administer Vimistal 1mg Oral Suspension as prescribed by your physician, adhering to the specified dosage and treatment length. Always consult the product label for usage instructions prior to consumption. Accurately measure the suspension using a measuring cup and ingest orally. Ensure thorough shaking before each dose. This medication should be taken on an empty stomach.
How Vimistal 1mg Oral Suspension works:
Reglan 1mg oral suspension stimulates gastrointestinal motility. Its action centers on the brain's emetic control center, while simultaneously enhancing upper digestive tract peristalsis to facilitate smoother food passage through the stomach.
SAFETY ADVICE
KidneyCAUTION
For individuals with severe kidney impairment, administration of Vimistal 1mg Oral Suspension necessitates careful consideration. Dosage modification of Vimistal 1mg Oral Suspension might be necessary. Physician consultation is advised. Regular assessment of kidney function, especially during prolonged treatment, is recommended.
LiverCAUTION
Caution is advised when administering 1mg Vimistal oral suspension to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. The use of 1mg Vimistal oral suspension is contraindicated in children exhibiting severe liver dysfunction. Pediatric consultation is required prior to administration.
What if you forget to take Vimistal 1mg Oral Suspension :
If your child's physician hasn't prescribed an alternative schedule, administer the forgotten dose upon recollection. Omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate, and adhere to the recommended dosage instructions.
Facts to Know About Vimistal 1mg Oral Suspension
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
| Action Class | Prokinetic agent with dopamine (D2) receptor antagonism |
